EVGN Relative Valuation
EVGN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, EVGN is overvalued; if below, it's undervalued.
Historical Valuation
Evogene Ltd (EVGN) is now in the Overvalued zone, suggesting that its current forward PS ratio of 3.53 is considered Overvalued compared with the five-year average of -2.09. The fair price of Evogene Ltd (EVGN) is between 0.24 to 0.73 according to relative valuation methord. Compared to the current price of 1.09 USD , Evogene Ltd is Overvalued By 48.89%.
Relative Value
Fair Zone
0.24-0.73
Current Price：1.09
48.89%
Overvalued
-0.94
PE
1Y
3Y
5Y
Trailing
Forward
-1.59
EV/EBITDA
Evogene Ltd. (EVGN) has a current EV/EBITDA of -1.59. The 5-year average EV/EBITDA is -0.56. The thresholds are as follows: Strongly Undervalued below -2.16, Undervalued between -2.16 and -1.36, Fairly Valued between 0.24 and -1.36, Overvalued between 0.24 and 1.04, and Strongly Overvalued above 1.04. The current Forward EV/EBITDA of -1.59 falls within the Undervalued range.
-1.07
EV/EBIT
Evogene Ltd. (EVGN) has a current EV/EBIT of -1.07. The 5-year average EV/EBIT is -1.29. The thresholds are as follows: Strongly Undervalued below -4.73, Undervalued between -4.73 and -3.01, Fairly Valued between 0.43 and -3.01, Overvalued between 0.43 and 2.15, and Strongly Overvalued above 2.15. The current Forward EV/EBIT of -1.07 falls within the Historic Trend Line -Fairly Valued range.
3.60
PS
Evogene Ltd. (EVGN) has a current PS of 3.60. The 5-year average PS is 45.55. The thresholds are as follows: Strongly Undervalued below -147.07, Undervalued between -147.07 and -50.76, Fairly Valued between 141.86 and -50.76, Overvalued between 141.86 and 238.16, and Strongly Overvalued above 238.16. The current Forward PS of 3.60 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Evogene Ltd. (EVGN) has a current P/OCF of 0.00. The 5-year average P/OCF is -1.95. The thresholds are as follows: Strongly Undervalued below -8.16, Undervalued between -8.16 and -5.05, Fairly Valued between 1.16 and -5.05, Overvalued between 1.16 and 4.26, and Strongly Overvalued above 4.26. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Evogene Ltd. (EVGN) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.21. The thresholds are as follows: Strongly Undervalued below -3.53, Undervalued between -3.53 and -1.66, Fairly Valued between 2.08 and -1.66, Overvalued between 2.08 and 3.95, and Strongly Overvalued above 3.95. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
Evogene Ltd (EVGN) has a current Price-to-Book (P/B) ratio of 8.09. Compared to its 3-year average P/B ratio of 1.39 , the current P/B ratio is approximately 483.66% higher. Relative to its 5-year average P/B ratio of 1.57, the current P/B ratio is about 415.13% higher. Evogene Ltd (EVGN) has a Forward Free Cash Flow (FCF) yield of approximately -172.94%. Compared to its 3-year average FCF yield of -122.22%, the current FCF yield is approximately 41.50% lower. Relative to its 5-year average FCF yield of -90.52% , the current FCF yield is about 91.06% lower.
8.40
P/B
Median3y
1.39
Median5y
1.57
-169.64
FCF Yield
Median3y
-122.22
Median5y
-90.52
Competitors Valuation Multiple
The average P/S ratio for EVGN's competitors is 1.20, providing a benchmark for relative valuation. Evogene Ltd Corp (EVGN) exhibits a P/S ratio of 3.60, which is 200.00% above the industry average. Given its robust revenue growth of -82.07%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of EVGN decreased by 41.18% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -0.47 to -0.76.
The secondary factor is the Margin Expansion, contributed -20.90%to the performance.
Overall, the performance of EVGN in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Evogene Ltd (EVGN) currently overvalued or undervalued?
What is Evogene Ltd (EVGN) fair value?
How does EVGN's valuation metrics compare to the industry average?
What is the current P/B ratio for Evogene Ltd (EVGN) as of Dec 05 2025?
What is the current FCF Yield for Evogene Ltd (EVGN) as of Dec 05 2025?
What is the current Forward P/E ratio for Evogene Ltd (EVGN) as of Dec 05 2025?